6814.TWO
Price:
$31.7
Market Cap:
$1.33B
Lukas Biomedical Inc. engages in the development of immune cell medical technology for regenerative medicine and auxiliary treatment of cancer in Taiwan. It operates through four divisions: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. The company also wholesales and retails cosmetics; and rents housing equipment. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2020-12-31
Stock Exchange
TWO
Ticker
6814.TWO
According to Lukas Biomedical Inc.’s latest financial reports and current stock price. The company's current ROE is -31.59%. This represents a change of 134.64% compared to the average of -13.46% of the last 4 quarters.
The mean historical ROE of Lukas Biomedical Inc. over the last ten years is -14.06%. The current -31.59% ROE has changed 124.68% with respect to the historical average. Over the past ten years (40 quarters), 6814.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the December 2024 quarter at -16.49%.
Average
-14.06%
Median
-16.10%
Minimum
-28.97%
Maximum
-2.32%
Discovering the peaks and valleys of Lukas Biomedical Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 376.37%
Maximum Annual ROE = -2.32%
Minimum Annual Increase = -11.44%
Minimum Annual ROE = -28.97%
| Year | ROE | Change |
|---|---|---|
| 2024 | -28.97% | 71.36% |
| 2023 | -16.90% | 10.56% |
| 2022 | -15.29% | -11.44% |
| 2021 | -17.26% | 376.37% |
| 2020 | -3.62% | 56.30% |
The current ROE of Lukas Biomedical Inc. (6814.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-20.39%
5-year avg
-16.41%
10-year avg
-14.06%
Lukas Biomedical Inc.’s ROE is greater than Bio Preventive Medicine Corp. (-24.73%), greater than LabTurbo Biotech Corporation (-12.54%), greater than LAUNXP Biomedical Co., Ltd (-56.54%), greater than MegaPro Biomedical Co., Ltd (-91.17%), less than Level Biotechnology Inc. (12.44%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%), greater than GeneReach Biotechnology Corp. (-19.92%), greater than Andros Pharmaceuticals Co.,Ltd (-18.09%), greater than Great Novel Therapeutics Biotech & Medicals (-14.66%), greater than Neith Corporation (-0.50%),
| Company | ROE | Market cap |
|---|---|---|
| -24.73% | $1.14B | |
| -12.54% | $1.12B | |
| -56.54% | $1.12B | |
| -91.17% | $1.02B | |
| 12.44% | $1.08B | |
| 9.19% | $1.05B | |
| -19.92% | $1.10B | |
| -18.09% | $1.26B | |
| -14.66% | $1.48B | |
| -0.50% | $1.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lukas Biomedical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lukas Biomedical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lukas Biomedical Inc.'s ROE?
How is the ROE calculated for Lukas Biomedical Inc. (6814.TWO)?
What is the highest ROE for Lukas Biomedical Inc. (6814.TWO)?
What is the 3-year average ROE for Lukas Biomedical Inc. (6814.TWO)?
What is the 5-year average ROE for Lukas Biomedical Inc. (6814.TWO)?
How does the current ROE for Lukas Biomedical Inc. (6814.TWO) compare to its historical average?